OMX Copenhagen PI
1 449,27
|
-34,80
|
-2,34%
|
Analysen zu OMX Copenhagen PI-Werten
04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
28.04.23 | Novo Nordisk Sell | UBS AG | |
27.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.04.23 | Novo Nordisk Overweight | Barclays Capital | |
18.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
18.04.23 | Novo Nordisk Buy | Deutsche Bank AG | |
14.04.23 | Novo Nordisk Sell | UBS AG | |
14.04.23 | Novo Nordisk Overweight | Barclays Capital | |
13.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.04.23 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.04.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
22.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
14.03.23 | Novo Nordisk Buy | Deutsche Bank AG |